Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: A substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Gv Matthews, J. Neuhaus, S. Bhagani, Sh Mehta, E. Vlahakis, M. Doroana, S. Naggie, A. Arenas-Pinto, L. Peters, Jk Rockstroh
Dive into the research topics of 'Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: A substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial'. Together they form a unique fingerprint.